• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] miR‑34a is downregulated in human osteosarcoma stem‑like cells and promotes invasion, tumorigenic ability and self‑renewal capacity.[已撤回] miR-34a在人骨肉瘤干细胞样细胞中表达下调,并促进侵袭、致瘤能力和自我更新能力。
Mol Med Rep. 2024 May;29(5). doi: 10.3892/mmr.2024.13196. Epub 2024 Mar 15.
2
[Retracted] MicroRNA‑584 prohibits hepatocellular carcinoma cell proliferation and invasion by directly targeting BDNF.[已撤回] 微小RNA‑584通过直接靶向脑源性神经营养因子抑制肝癌细胞的增殖和侵袭。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13248. Epub 2024 May 24.
3
[Retracted] MicroRNA‑336 directly targets Sox‑2 in osteosarcoma to inhibit tumorigenesis.
Mol Med Rep. 2024 Aug;30(2). doi: 10.3892/mmr.2024.13264. Epub 2024 Jun 21.
4
[Retracted] miR‑30a‑5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4.[已撤回] miR-30a-5p 通过靶向 SOX4 抑制黑色素瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13071. Epub 2023 Aug 18.
5
[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.[已撤回] 长链非编码RNA ROR通过miR-206/血管内皮生长因子轴促进肾细胞癌进展。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13229. Epub 2024 Apr 26.
6
[Retracted] MicroRNA‑539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF‑1R.[已撤回] 微小RNA-539通过调节胰岛素样生长因子1受体抑制膀胱癌细胞的增殖和侵袭。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13240. Epub 2024 May 17.
7
[Retracted] Downregulation of let‑7b promotes COL1A1 and COL1A2 expression in dermis and skin fibroblasts during heat wound repair.[已撤回] 在热损伤修复过程中,let-7b的下调促进真皮和皮肤成纤维细胞中COL1A1和COL1A2的表达。
Mol Med Rep. 2024 Feb;29(2). doi: 10.3892/mmr.2023.13144. Epub 2023 Dec 15.
8
[Retracted] MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.[已撤回] 微小RNA-320靶向丝裂原活化蛋白激酶1以抑制上皮性卵巢癌的细胞增殖和侵袭。
Mol Med Rep. 2024 Mar;29(3). doi: 10.3892/mmr.2024.13169. Epub 2024 Jan 26.
9
[Retracted] MicroRNA‑383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.[已撤回] 微小RNA-383通过直接靶向配对盒6抑制结直肠癌细胞的增殖和侵袭。
Mol Med Rep. 2023 Sep;28(3). doi: 10.3892/mmr.2023.13055. Epub 2023 Jul 21.
10
[Retracted] Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis.[已撤回] 丙泊酚通过miR-145-5p/TOP2A轴调节膀胱癌细胞的增殖、侵袭和迁移。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13218. Epub 2024 Apr 12.

[已撤回] miR-34a在人骨肉瘤干细胞样细胞中表达下调,并促进侵袭、致瘤能力和自我更新能力。

[Retracted] miR‑34a is downregulated in human osteosarcoma stem‑like cells and promotes invasion, tumorigenic ability and self‑renewal capacity.

作者信息

Zou Yonggen, Huang Yuanshuai, Yang Jiexiang, Wu Jian, Luo Cheng

机构信息

Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.

Department of Transfusion, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.

出版信息

Mol Med Rep. 2024 May;29(5). doi: 10.3892/mmr.2024.13196. Epub 2024 Mar 15.

DOI:10.3892/mmr.2024.13196
PMID:38488032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10955509/
Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell invasion assay data shown in Fig. 4B on p. 1635 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were submitted at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 15: 1631‑1637, 2017; DOI: 10.3892/mmr.2017.6187].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,第1635页图4B所示的某些Transwell细胞侵袭试验数据与不同研究机构的不同作者撰写的其他文章中以不同形式出现的数据惊人地相似,这些文章要么已经发表,要么大约在同一时间提交。由于上述文章中存在争议的数据在提交给本期刊之前已经发表,编辑决定从本期刊撤回这篇论文。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者表示歉意。[《分子医学报告》15: 1631 - 1637, 2017; DOI: 10.3892/mmr.2017.6187]